Sixth Street Growth
Christopher Schaefer, Ph.D. is a seasoned professional in the healthcare investment sector, serving as Managing Director at Sixth Street since January 2017, where Christopher has also held the titles of Principal and Vice President. Prior experience includes serving as Vice President of Investment Analysis and Research at DRI Capital from June 2011 to December 2016, contributing to the firm's leadership in healthcare royalty investing. Earlier roles encompassed positions at UBS as a Small/Mid-Cap US Biotechnology Analyst and Associate Research Analyst, as well as a Post-Doctoral Fellow at Columbia University Medical Center, focusing on epigenetics research. Christopher Schaefer holds a BA in Biology from Rutgers University - Newark and a Ph.D. in Microbiology and Molecular Genetics from the University of Medicine and Dentistry of New Jersey.
This person is not in any teams
Sixth Street Growth
2 followers
Sixth Street is a global investment firm with over $50 billion in assets under management. They operate nine diversified, collaborative investment platforms: TAO, Growth, Specialty Lending, Fundamental Strategies, Infrastructure, Insurance, Opportunities, Agriculture, and Credit Market Strategies.